Spectrum Pharma (SPPI) Tops Q4 EPS by 25c

March 13, 2015 7:24 AM EDT

Spectrum Pharma (NASDAQ: SPPI) reported Q4 EPS of $0.09, $0.25 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $51.7 million versus the consensus estimate of $48.5 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings